{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T19:06:05Z","timestamp":1788721565014,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a critical condition characterized by a dysregulated immune response to infection. As sepsis develops to septic shock, its most severe form, morbidity and mortality increases. Hyaluronan is a key component of the extracellular matrix and the endothelial glycocalyx. In sepsis, plasma hyaluronan concentrations are increased and correlate with disease severity. In this study we aimed to explore and compare the proteomic profiles of hyaluronan-associated proteins in patients with the dysregulated immune response of septic shock and the sterile inflammation of acute alcohol-related pancreatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present study involved proteomic analysis of patients with septic shock (n\u2009=\u200913), pancreatitis (n\u2009=\u20098), and healthy controls (n\u2009=\u20098). LC\u2013MS\/MS was conducted for peptide analysis. Hyaluronan-associated proteins were identified using the UniProt REST API, followed by functional and pathway enrichment analyses with GOATOOLS and GSEApy. Statistical analyses, including ANOVA and post hoc tests, were performed using Python and SPSS, with significance set at p\u2009&lt;\u20090.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From a total sum of 663 detected unique plasma proteins, 15 were identified as hyaluronan-related proteins. Plasma levels of 11\/15 proteins separated septic shock from pancreatitis in a statistically significant manner. Between the groups differences were apparent on day 1 (8 proteins in septic shock versus 3 in pancreatitis) and day 4 (6 proteins in septic shock versus 3 in pancreatitis) relative to controls. Functional enrichment analysis revealed associations with extracellular matrix organization, proteolytic enzyme regulation, and hyaluronan metabolism. Notably, members of the inter-alpha-inhibitor family demonstrated distinct patterns, with ITIH3 levels increasing and ITIH1, ITIH2, and ITIH4 levels decreasing in septic shock compared to controls. Additionally, plasma hyaluronidase inhibition correlated positively with ITIH3 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The present study explored the role of hyaluronan-related proteins in septic shock pathophysiology, revealing potential dysregulation associated with sepsis severity. The decrease in ITIH1, ITIH2 and ITIH4, as compared to the increase in ITIH3, suggest a complex alteration in the protein balance of the I\u03b1I-family in sepsis. Overall, the altered proteomic profile of hyaluronan-related proteins as reflected by the GO terms indicates a complex dysregulation not only in hyaluronan metabolism and extracellular matrix, but also in the regulation of several proteolytic enzymes. Future studies on this area are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12014-025-09556-2","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T07:37:29Z","timestamp":1756539449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma proteomics in septic shock and alcohol-related pancreatitis: a hyaluronan-centered approach"],"prefix":"10.1186","volume":"22","author":[{"given":"Jaap","family":"van der Heijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asanda","family":"Mazubane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Sallisalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor","family":"Vorontsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyrki","family":"Tenhunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Barrueta Tenhunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"9556_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"9556_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"9556_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5:816\u201326.","journal-title":"Lancet Respir Med"},{"key":"9556_CR4","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317.","journal-title":"JAMA"},{"key":"9556_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","volume":"11","author":"P Sinha","year":"2023","unstructured":"Sinha P, Kerchberger VE, Willmore A, Chambers J, Zhuo H, Abbott J, et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir Med. 2023;11:965\u201374.","journal-title":"Lancet Respir Med"},{"key":"9556_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/prca.201300101","volume":"8","author":"Z Cao","year":"2014","unstructured":"Cao Z, Robinson RAS. The role of proteomics in understanding biological mechanisms of sepsis. Proteomics Clin Appl. 2014;8:35\u201352.","journal-title":"Proteomics Clin Appl"},{"key":"9556_CR7","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101091","volume":"4","author":"X Liang","year":"2021","unstructured":"Liang X, Wu T, Chen Q, Jiang J, Jiang Y, Ruan Y, et al. Serum proteomics reveals disorder of lipoprotein metabolism in sepsis. Life Sci Alliance. 2021;4: e202101091.","journal-title":"Life Sci Alliance"},{"key":"9556_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh0185","volume":"16","author":"Y Mi","year":"2024","unstructured":"Mi Y, Burnham KL, Charles PD, Heilig R, Vendrell I, Whalley J, et al. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response. Sci Transl Med. 2024;16: eadh0185.","journal-title":"Sci Transl Med"},{"key":"9556_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733537","volume":"12","author":"H Miao","year":"2021","unstructured":"Miao H, Chen S, Ding R. Evaluation of the molecular mechanisms of sepsis using proteomics. Front Immunol. 2021;12: 733537.","journal-title":"Front Immunol"},{"key":"9556_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12931-023-02364-y","volume":"24","author":"LM Palma Medina","year":"2023","unstructured":"Palma Medina LM, Baba\u010di\u0107 H, Dzidic M, Parke \u00c5, Garcia M, Maleki KT, et al. Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia. Respir Res. 2023;24:62.","journal-title":"Respir Res"},{"key":"9556_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/SHK.0000000000000698","volume":"47","author":"NK Sharma","year":"2017","unstructured":"Sharma NK, Salomao R. Sepsis through the eyes of proteomics: the progress in the last decade. Shock. 2017;47:17\u201325.","journal-title":"Shock"},{"key":"9556_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","volume":"242","author":"JR Fraser","year":"1997","unstructured":"Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27\u201333.","journal-title":"J Intern Med"},{"key":"9556_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.mvr.2010.06.005","volume":"80","author":"L Gao","year":"2010","unstructured":"Gao L, Lipowsky HH. Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes. Microvasc Res. 2010;80:394\u2013401.","journal-title":"Microvasc Res"},{"key":"9556_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2019.02.002","volume":"78\u201379","author":"S Garantziotis","year":"2019","unstructured":"Garantziotis S, Savani RC. Hyaluronan biology: A complex balancing act of structure, function, location and context. Matrix Biol. 2019;78\u201379:1\u201310.","journal-title":"Matrix Biol"},{"key":"9556_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/biom10111525","volume":"10","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Chanmee T, Itano N. Hyaluronan: metabolism and function. Biomolecules. 2020;10:1525.","journal-title":"Biomolecules"},{"key":"9556_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/physrev.00052.2009","volume":"91","author":"D Jiang","year":"2011","unstructured":"Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91:221\u201364.","journal-title":"Physiol Rev"},{"key":"9556_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/abbi.1997.9970","volume":"341","author":"M Li","year":"1997","unstructured":"Li M, Rosenfeld L, Vilar RE, Cowman MK. Degradation of hyaluronan by peroxynitrite. Arch Biochem Biophys. 1997;341:245\u201350.","journal-title":"Arch Biochem Biophys"},{"key":"9556_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0925-4439(97)00083-5","volume":"1362","author":"R Moseley","year":"1997","unstructured":"Moseley R, Waddington RJ, Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim Biophys Acta. 1997;1362:221\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"9556_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-10-23","volume":"10","author":"KE Black","year":"2013","unstructured":"Black KE, Collins SL, Hagan RS, Hamblin MJ, Chan-Li Y, Hallowell RW, et al. Hyaluronan fragments induce IFN\u03b2 via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. J Inflamm. 2013;10: 23.","journal-title":"J Inflamm"},{"key":"9556_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3109\/00365518809088752","volume":"48","author":"S Berg","year":"1988","unstructured":"Berg S, Brodin B, Hesselvik F, Laurent TC, Maller R. Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest. 1988;48:727\u201332.","journal-title":"Scand J Clin Lab Invest"},{"key":"9556_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clinbiochem.2011.10.016","volume":"45","author":"E Yagmur","year":"2012","unstructured":"Yagmur E, Koch A, Haumann M, Kramann R, Trautwein C, Tacke F. Hyaluronan serum concentrations are elevated in critically ill patients and associated with disease severity. Clin Biochem. 2012;45:82\u20137.","journal-title":"Clin Biochem"},{"key":"9556_CR22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.clinbiochem.2016.02.014","volume":"49","author":"D Anand","year":"2016","unstructured":"Anand D, Ray S, Srivastava LM, Bhargava S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients. Clin Biochem. 2016;49:768\u201376.","journal-title":"Clin Biochem"},{"key":"9556_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1164\/rccm.201511-2281OC","volume":"194","author":"EP Schmidt","year":"2016","unstructured":"Schmidt EP, Overdier KH, Sun X, Lin L, Liu X, Yang Y, et al. Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2016;194:439\u201349.","journal-title":"Am J Respir Crit Care Med"},{"key":"9556_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jcrc.2017.07.001","volume":"42","author":"L Smart","year":"2017","unstructured":"Smart L, Macdonald SPJ, Burrows S, Bosio E, Arendts G, Fatovich DM. Endothelial glycocalyx biomarkers increase in patients with infection during emergency department treatment. J Crit Care. 2017;42:304\u20139.","journal-title":"J Crit Care"},{"key":"9556_CR25","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/00003246-199410000-00010","volume":"22","author":"S Berg","year":"1994","unstructured":"Berg S, Engman A, Hesselvik JF, Laurent TC. Crystalloid infusion increases plasma hyaluronan. Crit Care Med. 1994;22:1563\u20137.","journal-title":"Crit Care Med"},{"key":"9556_CR26","doi-asserted-by":"publisher","first-page":"20808","DOI":"10.1038\/s41598-024-71670-2","volume":"14","author":"M Serlo","year":"2024","unstructured":"Serlo M, Inkinen N, Lakkisto P, Valkonen M, Pulkkinen A, Selander T, et al. Fluid bolus increases plasma hyaluronan concentration compared to follow-up strategy without a bolus in oliguric intensive care unit patients. Sci Rep. 2024;14:20808.","journal-title":"Sci Rep"},{"key":"9556_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-021-00418-3","volume":"9","author":"J van der Heijden","year":"2021","unstructured":"van der Heijden J, Kolliopoulos C, Skorup P, Sallisalmi M, Heldin P, Hultstr\u00f6m M, et al. Plasma hyaluronan, hyaluronidase activity and endogenous hyaluronidase inhibition in sepsis: an experimental and clinical cohort study. Intensive Care Med Exp. 2021;9: 53.","journal-title":"Intensive Care Med Exp"},{"key":"9556_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1399-6576.2011.02578.x","volume":"56","author":"M Sallisalmi","year":"2012","unstructured":"Sallisalmi M, Tenhunen J, Yang R, Oksala N, Pettil\u00e4 V. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiol Scand. 2012;56:316\u201322.","journal-title":"Acta Anaesthesiol Scand"},{"key":"9556_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28948-z","volume":"8","author":"DV Klopfenstein","year":"2018","unstructured":"Klopfenstein DV, Zhang L, Pedersen BS, Ram\u00edrez F, Warwick Vesztrocy A, Naldi A, et al. Goatools: a Python library for gene ontology analyses. Sci Rep. 2018;8: 10872.","journal-title":"Sci Rep"},{"key":"9556_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90\u20135.","journal-title":"Comput Sci Eng"},{"key":"9556_CR31","doi-asserted-by":"publisher","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang Z, Liu X, Peltz G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics. 2023;39:btac757.","journal-title":"Bioinformatics"},{"key":"9556_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/03008200802325458","volume":"49","author":"L Zhuo","year":"2008","unstructured":"Zhuo L, Kimata K. Structure and function of inter-alpha-trypsin inhibitor heavy chains. Connect Tissue Res. 2008;49:311\u201320.","journal-title":"Connect Tissue Res"},{"key":"9556_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1432224","volume":"11","author":"X-F Zhang","year":"2024","unstructured":"Zhang X-F, Zhang X-L, Guo L, Bai Y-P, Tian Y, Luo H-Y. The function of the inter-alpha-trypsin inhibitors in the development of disease. Front Med. 2024;11: 1432224.","journal-title":"Front Med"},{"key":"9556_CR34","doi-asserted-by":"publisher","first-page":"26725","DOI":"10.1016\/S0021-9258(19)74373-7","volume":"268","author":"L Huang","year":"1993","unstructured":"Huang L, Yoneda M, Kimata K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 1993;268:26725\u201330.","journal-title":"J Biol Chem"},{"key":"9556_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/rep.0.1250027","volume":"125","author":"TE Jessen","year":"2003","unstructured":"Jessen TE, \u00d8dum L. Role of tumour necrosis factor stimulated gene 6 (TSG-6) in the coupling of inter-alpha-trypsin inhibitor to hyaluronan in human follicular fluid. Reproduction. 2003;125:27\u201331.","journal-title":"Reproduction"},{"issue":"Pt 1","key":"9556_CR36","first-page":"1","volume":"315","author":"JP Salier","year":"1996","unstructured":"Salier JP, Rouet P, Raguenez G, Daveau M. The inter-alpha-inhibitor family: from structure to regulation. Biochem J. 1996;315(Pt 1):1\u20139.","journal-title":"Biochem J"},{"key":"9556_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1086\/377642","volume":"188","author":"Y-P Lim","year":"2003","unstructured":"Lim Y-P, Bendelja K, Opal SM, Siryaporn E, Hixson DC, Palardy JE. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis. 2003;188:919\u201326.","journal-title":"J Infect Dis"},{"key":"9556_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.CCM.0000253810.08230.83","volume":"35","author":"SM Opal","year":"2007","unstructured":"Opal SM, Lim Y-P, Siryaporn E, Moldawer LL, Pribble JP, Palardy JE, et al. Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis. Crit Care Med. 2007;35:387\u201392.","journal-title":"Crit Care Med"},{"key":"9556_CR39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fphar.2019.01370","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Liu B, Tang Y, Chang P, Yao L, Huang B, et al. Improvement of sepsis prognosis by ulinastatin: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2019;10:1370.","journal-title":"Front Pharmacol"},{"key":"9556_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jcrc.2016.12.013","volume":"39","author":"D Liu","year":"2017","unstructured":"Liu D, Yu Z, Yin J, Chen Y, Zhang H, Xin F, et al. Effect of ulinastatin combined with thymosin alpha1 on sepsis: a systematic review and meta-analysis of Chinese and Indian patients. J Crit Care. 2017;39:259\u201366.","journal-title":"J Crit Care"},{"key":"9556_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcrc.2018.01.021","volume":"45","author":"JY Lagoo","year":"2018","unstructured":"Lagoo JY, D\u2019Souza MC, Kartha A, Kutappa AM. Role of ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: a retrospective analysis. J Crit Care. 2018;45:27\u201332.","journal-title":"J Crit Care"},{"issue":"Pt 2","key":"9556_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1042\/bj2920485","volume":"292","author":"M Daveau","year":"1993","unstructured":"Daveau M, Rouet P, Scotte M, Faye L, Hiron M, Lebreton JP, et al. Human inter-alpha-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins. Biochem J. 1993;292(Pt 2):485\u201392.","journal-title":"Biochem J"},{"key":"9556_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12014-020-09288-5","volume":"17","author":"T Thavarajah","year":"2020","unstructured":"Thavarajah T, Dos Santos CC, Slutsky AS, Marshall JC, Bowden P, Romaschin A, et al. The plasma peptides of sepsis. Clin Proteomics. 2020;17:26.","journal-title":"Clin Proteomics"},{"key":"9556_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100078","volume":"7","author":"JB Larsen","year":"2023","unstructured":"Larsen JB, Pihl R, Aggerbeck MA, Larsen KM, Hvas CL, Johnsen N, et al. Inter-\u03b1-inhibitor heavy chain H4 and sepsis-related coagulation disturbances: another link between innate immunity and coagulation. Res Pract Thromb Haemost. 2023;7: 100078.","journal-title":"Res Pract Thromb Haemost"},{"key":"9556_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24834","volume":"37","author":"X Zhao","year":"2023","unstructured":"Zhao X, Guo Y, Li L, Li Y. Longitudinal change of serum inter-alpha-trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis. J Clin Lab Anal. 2023;37: e24834.","journal-title":"J Clin Lab Anal"},{"key":"9556_CR46","doi-asserted-by":"publisher","first-page":"32413","DOI":"10.1074\/jbc.M005428200","volume":"275","author":"K Mio","year":"2000","unstructured":"Mio K, Carrette O, Maibach HI, Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family. J Biol Chem. 2000;275:32413\u201321.","journal-title":"J Biol Chem"},{"key":"9556_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.898592","volume":"9","author":"EK Patterson","year":"2022","unstructured":"Patterson EK, Cepinskas G, Fraser DD. Endothelial glycocalyx degradation in critical illness and injury. Front Med. 2022;9: 898592.","journal-title":"Front Med"},{"key":"9556_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2024.104683","volume":"154","author":"N Soubihe Neto","year":"2024","unstructured":"Soubihe Neto N, de Almeida MCV, Couto HdeO, Miranda CH. Biomarkers of endothelial glycocalyx damage are associated with microvascular dysfunction in resuscitated septic shock patients. Microvasc Res. 2024;154: 104683.","journal-title":"Microvasc Res"},{"key":"9556_CR49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1083\/jcb.144.4.789","volume":"144","author":"S Banerji","year":"1999","unstructured":"Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789\u2013801.","journal-title":"J Cell Biol"},{"key":"9556_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.matbio.2018.02.001","volume":"78\u201379","author":"DG Jackson","year":"2019","unstructured":"Jackson DG. Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking. Matrix Biol. 2019;78\u201379:219\u201335.","journal-title":"Matrix Biol"},{"key":"9556_CR51","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fimmu.2020.00512","volume":"11","author":"TN Wight","year":"2020","unstructured":"Wight TN, Kang I, Evanko SP, Harten IA, Chang MY, Pearce OMT, et al. Versican-a critical extracellular matrix regulator of immunity and inflammation. Front Immunol. 2020;11:512.","journal-title":"Front Immunol"},{"key":"9556_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1533\/9781845693121.497","volume-title":"hyaluronan","author":"M Zhao","year":"2002","unstructured":"Zhao M, Yoneda M, Zhuo L, Huang L, Watanabe H, Yamada Y, et al. Proteoglycan enhances the formation of the shap-hyaluronan complex and its effect in hyaluronan-rich matrix. In: Kennedy JF, Phillips GO, Williams PA, editors., et al., hyaluronan. Woodhead Publishing; 2002. p. 497\u2013500."},{"key":"9556_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/ATVBAHA.109.200451","volume":"30","author":"N Mambetsariev","year":"2010","unstructured":"Mambetsariev N, Mirzapoiazova T, Mambetsariev B, Sammani S, Lennon FE, Garcia JGN, et al. Hyaluronic acid binding protein 2 is a novel regulator of vascular integrity. Arterioscler Thromb Vasc Biol. 2010;30:483\u201390.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-025-09556-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:18:35Z","timestamp":1756898315000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-025-09556-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9556"],"URL":"https:\/\/doi.org\/10.1186\/s12014-025-09556-2","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethical committee of the Helsinki University Hospital (permit number 101\/13\/03\/02\/08) and conducted in accordance with the Declaration of Helsinki. Prior to enrolment, written consent for participation in the study was obtained from either the patient or their next of kin. The confidentiality of participants\u2019 information was maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}